Executive Summary
This comprehensive evidence synthesis examines current renal imaging modalities including computed tomography (CT) stone protocols and urography, renal ultrasonography, arterial duplex studies, nuclear medicine scintigraphy, and magnetic resonance imaging (MRI). The analysis incorporates recent developments in contrast-associated versus contrast-induced nephropathy terminology and updated guidelines for gadolinium-based contrast agent use, particularly regarding nephrogenic systemic fibrosis (NSF) risk stratification. Evidence demonstrates evolving understanding of contrast nephropathy causality and significant risk reduction with Group II gadolinium agents in patients with advanced CKD.
Table of Contents
CT Imaging: Stone Protocols, Urography, and Mass Evaluation
Non-Contrast CT Stone Protocols
Non-contrast CT represents the gold standard for urolithiasis detection, demonstrating sensitivity of 94–100% and specificity of 92–100% for identifying urinary calculi. The technique detects all stone compositions except rare indinavir and matrix stones, providing comprehensive evaluation without contrast administration.
Low-dose CT stone protocols achieve effective doses of 1.5–3.5 mSv while maintaining diagnostic accuracy above 95% for stones ≥3 mm. Ultra-low-dose protocols (<1.5 mSv) show promise for surveillance and follow-up, though reduced sensitivity for small stones and subtle findings requires consideration.
Dual-energy CT enables stone composition analysis, differentiating uric acid from non-uric acid stones with high accuracy. This guides treatment selection between medical dissolution therapy and surgical intervention — particularly valuable for patients with multiple stones of potentially different compositions.
CT vs. Ultrasound: Comparative Performance
| Parameter | Non-Contrast CT | Ultrasonography |
|---|---|---|
| Sensitivity (overall) | 94–100% | 45–70% |
| Sensitivity (stones >5mm) | >99% | 80–90% |
| Specificity | 92–100% | 70–90% |
| Radiation | 1.5–7 mSv | None |
| Best for | Comprehensive evaluation, surgical planning | Screening, pregnancy, pediatrics, serial monitoring |
Renal Size Measurement: CT vs. Ultrasound
CT measurements demonstrate superior accuracy with lower inter-observer variability compared to ultrasonography. CT provides consistent measurement in standardized planes regardless of patient habitus, while ultrasound measurements vary by 1–2 cm based on operator technique, imaging plane, and patient positioning.
Cystic Lesion Evaluation (Bosniak Classification)
CT demonstrates excellent sensitivity approaching 95% for detecting cystic lesions and provides detailed Bosniak classification. Ultrasound demonstrates excellent sensitivity for simple cysts (>1 cm) but has false negative rates exceeding 40% for complex features (thin septations, minimal wall thickening).
Solid Mass Detection
CT sensitivity exceeds 95% for masses >1 cm with near-perfect specificity for distinguishing solid from cystic lesions. Ultrasound sensitivity ranges from 60–85% with false negative rates of 15–40% for masses <2 cm or isoechoic lesions.
CT Urography
CT urography combines non-contrast, nephrographic phase (80–100 seconds post-contrast), and delayed excretory phase (8–15 minutes post-contrast) for comprehensive urinary tract evaluation. Has largely replaced intravenous urography for hematuria workup and collecting system evaluation.
Renal Ultrasonography
Renal ultrasonography provides radiation-free, readily available imaging for multiple clinical applications. Point-of-care ultrasonography (POCUS) has gained prominence in emergency department evaluation of suspected nephrolithiasis, with comparable diagnostic accuracy to CT for detecting clinically significant hydronephrosis.
- Renal dimensions and cortical thickness assessment
- Collecting system dilatation (hydronephrosis)
- Guidance for interventional procedures (biopsy)
- Pregnancy, pediatric, and serial monitoring settings
- Absence of ionizing radiation
Advanced Ultrasound Technologies
Contrast-Enhanced Ultrasound (CEUS)
Utilizes microbubble contrast agents to enhance vascular visualization and tissue perfusion assessment without nephrotoxicity. Particularly valuable in patients with compromised renal function where traditional contrast agents are contraindicated. Applications include renal mass characterization, post-ablation treatment response, and transplant perfusion evaluation.
Elastography
Enables non-invasive assessment of tissue stiffness correlating with renal fibrosis. Shows potential for reducing the need for renal biopsy in selected cases and for longitudinal monitoring of CKD progression.
Renal Arterial Duplex Ultrasonography
Diagnostic Criteria for RAS
| Parameter | Threshold | Interpretation |
|---|---|---|
| Peak systolic velocity (PSV) | >200 cm/s | Hemodynamically significant stenosis (≥60%) |
| Renal-aortic ratio (RAR) | >3.5 | Additional diagnostic information |
| In-stent restenosis PSV | >395 cm/s | Significant in-stent restenosis |
Sensitivity ranges from 85–92% with specificity of 85–95% using established criteria. Contrast-enhanced duplex (CEDUS) with SonoVue demonstrates improved performance, particularly for moderate-grade stenoses.
Duplex vs. CT Angiography for RAS
| Feature | Duplex Ultrasound | CT Angiography |
|---|---|---|
| Sensitivity | 85–95% | 94–100% |
| Specificity | 85–95% | 92–100% |
| Contrast required | No | Yes (iodinated) |
| Radiation | None | 3–7 mSv |
| Operator dependence | High | Low |
| Failure rate (obesity) | 20–30% | <5% |
| Cost | 30–50% of CTA | Higher |
| Best for | Screening, serial monitoring, CKD patients | Definitive anatomy, surgical planning |
Duplex: Inappropriate angle correction, systemic hypertension elevating velocities, turbulent flow misinterpretation. CTA: Motion artifacts, vessel tortuosity mimicking stenosis, calcium deposits obscuring lumen (primarily elderly patients).
Nuclear Medicine Renal Scintigraphy
Dynamic Renal Scintigraphy with Diuretic Challenge (Lasix Renogram)
Standard approach for differentiating obstructive from non-obstructive hydronephrosis. Tc-99m MAG3 demonstrates superior imaging characteristics compared to Tc-99m DTPA.
| T½ after Furosemide | Interpretation |
|---|---|
| <10 minutes | Effectively excludes significant obstruction |
| 10–20 minutes | Indeterminate — requires clinical correlation |
| >20 minutes | Suggests obstructive pathophysiology |
Captopril Renography
Evaluates renovascular hypertension by assessing renal function before and after ACE inhibition. Exploits dependence of GFR on efferent arteriolar vasoconstriction in stenotic kidneys. Clinical utility has diminished with improved cross-sectional imaging but retains value for functional assessment guiding therapeutic decisions.
DMSA Cortical Scintigraphy
Provides high-resolution cortical imaging for detecting renal scarring, acute pyelonephritis, and differential renal function. Superior sensitivity compared to ultrasonography for cortical scarring, particularly in pediatric populations.
Magnetic Resonance Imaging
Non-Contrast MRI Applications
- Diffusion-weighted imaging (DWI): Functional information regarding cellular density; distinguishing benign from malignant renal lesions
- Time-of-flight MR angiography: Contrast-free renal vasculature evaluation
- BOLD imaging: Assessment of renal oxygenation without contrast
- Arterial spin labeling (ASL): Renal perfusion evaluation without contrast
Contrast-Enhanced MRI
Dynamic contrast-enhanced sequences provide renal perfusion, glomerular filtration, and collecting system anatomy. Arterial phase enhances vasculature and hypervascular lesions; nephrographic phase provides optimal parenchymal enhancement for mass detection.
MR Elastography
Provides quantitative assessment of tissue stiffness with superior reproducibility and less operator dependence than ultrasound elastography. Correlates with histological fibrosis in CKD and transplant recipients.
Contrast Administration Considerations
Iodinated Contrast: CIN vs. CAN Terminology
The evolution from contrast-induced nephropathy (CIN) to contrast-associated nephropathy (CAN) reflects improved understanding that many factors beyond contrast exposure contribute to post-procedural renal dysfunction. The ACR now uses “contrast-associated acute kidney injury” (CA-AKI) for any deterioration within 48 hours, reserving “contrast-induced” (CI-AKI) for probable causal cases.
Incidence of Creatinine Elevation Following CTA
| Population | Creatinine Elevation Rate |
|---|---|
| General population | 2–7% |
| High-risk (CKD, diabetes, elderly) | 12–27% |
| eGFR <30 mL/min/1.73m² | 15–30% |
| Normal renal function, no diabetes | <2–3% |
| True CI-AKI (IV contrast) | Possibly <1–2% |
IV contrast administration results in lower rates of renal dysfunction compared to intra-arterial procedures (1–5% vs. 5–15%). Large retrospective studies demonstrate that many patients who develop post-CTA creatinine elevation have alternative explanations including underlying illness, medication effects, or hemodynamic instability.
Gadolinium-Based Contrast Agents (GBCAs) and NSF
| Group | NSF Risk | Agents | CKD Guidance |
|---|---|---|---|
| Group I | Highest | Gadodiamide (Omniscan), Gadopentetate (Magnevist), Gadoversetamide (OptiMARK) | Contraindicated in advanced CKD |
| Group II | Lowest | Gadoteridol (ProHance), Gadoterate (Dotarem), Gadobutrol (Gadavist) | Supported when clinically indicated, even eGFR <30 |
| Group III | Intermediate/Unknown | Various | Caution in advanced CKD |
A systematic review and meta-analysis of over 4,900 Group II GBCA administrations to patients with eGFR <30 mL/min/1.73m² found no unconfounded cases of NSF. This has prompted significant liberalization of Group II GBCA administration guidelines. Use the lowest effective dose and separate repeat administrations by at least 7 days when possible. Ref: Woolen SA, et al. JAMA Intern Med. 2020. PubMed
Advanced and Emerging Technologies
Dual-Energy CT
Enables material characterization beyond conventional CT. Established for stone composition analysis (uric acid vs. non-uric acid). Virtual non-contrast imaging can eliminate true non-contrast phases. Quantitative iodine mapping enhances perfusion assessment.
Photoacoustic Imaging
Combines optical contrast with ultrasonic detection for tissue oxygenation and hemoglobin content visualization. Early renal applications focus on oxygenation assessment and potential AKI detection before conventional biomarkers become abnormal. Largely investigational.
Optical Coherence Tomography
High-resolution cross-sectional imaging approaching histological resolution. Renal applications include endoscopic assessment of collecting system pathology. Limited by penetration depth to superficial tissues accessible endoscopically.
Interventional and Fluoroscopic Imaging
Essential for percutaneous nephrostomy, ureteral stent insertion, percutaneous stone removal, and renal biopsy guidance. Contemporary equipment incorporates pulsed fluoroscopy, filtration optimization, and real-time dose monitoring.
References
- Montatore M, et al. Current status on new technique and protocol in urinary stone disease. Curr Radiol Rep. 2023;11(6):161-176.
- Moore CL, et al. Imaging in suspected renal colic: systematic review and multispecialty consensus. J Urol. 2019;202(3):475-483.
- Fulgham PF, et al. Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment. J Urol. 2013;189(4):1203-1213.
- Smith RC, et al. Acute flank pain: comparison of non-contrast-enhanced CT and intravenous urography. Radiology. 1995;194(3):789-794.
- Israel GM, Bosniak MA. An update of the Bosniak renal cyst classification system. Urology. 2005;66(3):484-488.
- Zhang J, et al. Solid renal cortical tumors: differentiation with CT. Radiology. 2007;244(2):494-504.
- Beland MD, et al. Renal cortical thickness measured at ultrasound: is it better than renal length as an indicator of renal function in chronic kidney disease? AJR. 2010;195(2):W146-149.
- Vasbinder GB, et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med. 2001;135(6):401-411.
- Williams GJ, et al. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis. AJR. 2007;188(3):798-811.
- Taylor AT Jr, et al. SNMMI/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults. Semin Nucl Med. 2018;48(4):377-390.
- Piepsz A, et al. Guidelines for 99mTc-DMSA scintigraphy in children. Eur J Nucl Med. 2001;28(3):BP37-41.
- Aycock RD, et al. Acute kidney injury after computed tomography: a meta-analysis. Ann Emerg Med. 2018;71(1):44-53. PubMed
- McDonald RJ, et al. Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology. 2013;267(1):106-118.
- Davenport MS, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from ACR and NKF. Radiology. 2020;294(3):660-668.
- Woolen SA, et al. Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 CKD receiving a Group II GBCA: a systematic review and meta-analysis. JAMA Intern Med. 2020;180(2):223-230. PubMed
- Graser A, et al. Dual energy CT characterization of urinary calculi. Invest Radiol. 2008;43(2):112-119.
- Kirpalani A, et al. Magnetic resonance elastography to assess fibrosis in kidney allografts. Clin J Am Soc Nephrol. 2017;12(10):1671-1679.
- Radermacher J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344(6):410-417.
- Claudon M, et al. Guidelines for contrast enhanced ultrasound (CEUS) in the liver. Ultraschall Med. 2013;34(1):11-29.
- Wang R, et al. Effect of an ultrasound-first clinical decision tool in emergency department patients with suspected nephrolithiasis. Am J Emerg Med. 2022;60:164-170.